Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

Université Laval

$133,787.00

Enhancing adherence to adjuvant endocrine therapy among breast cancer survivors: Pilot study of the S.O.I.E. program

FY 2015-16

Summary
Each year, 15,000 Canadian women receive a diagnosis of hormone-sensitive breast cancer and are likely to be prescribed adjuvant endocrine therapy (AET) for 5 or 10 years. AET significantly reduces recurrence and mortality risks. However, non-adherence to AET is common and 31-47% of women do not persist with AET for the recommended minimum of 5 years. Non-adherence to AET has been associated with higher mortality risks and healthcare costs. The few AET adherence-enhancing interventions evaluated were mainly limited to the provision of information and reminders, with inconclusive results. Our team has developed the "SOIE" (Soutien, Outils, Information, Entraide) program for women who have a first AET prescription. This program, developed in collaboration with clinicians and breast cancer survivors, includes group sessions (in person and online) and short individual interventions tailored to women's needs. We will pilot-test the SOIE program to evaluate: a) effect of the program on factors expected to influence AET adherence; b) program acceptability; c) feasibility of program delivery; d) feasibility of conducting a large-scale study to evaluate cost-effectiveness. We will conduct a pilot randomized controlled trial (RCT). Fifty (50) women will receive the program and 50 women will receive the usual care. Quantitative and qualitative data will be collected among participating women and health professionals delivering the program. Results from this study will provide crucial information for program optimization and for the design of the large-scale multicenter RCT. This pilot study represents the cornerstone for the implementation of a novel program that has the potential to contribute to the efforts to improve both breast cancer survival and the survivorship experience.
Program
Project Grant
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
347376
Name
Lauzier Sophie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Project Grant Competition
Projecttitle
Enhancing adherence to adjuvant endocrine therapy among breast cancer survivors: Pilot study of the S.O.I.E. program
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$133,787
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Adherence; Adjuvant Endocrine Therapy; Breast Cancer; Intervention Development And Evaluation; Mixed-Methods (Qualitative And Quantitative); Pilot Study; Support Care; Survivorship
Abstract
Each year, 15,000 Canadian women receive a diagnosis of hormone-sensitive breast cancer and are likely to be prescribed adjuvant endocrine therapy (AET) for 5 or 10 years. AET significantly reduces recurrence and mortality risks. However, non-adherence to AET is common and 31-47% of women do not persist with AET for the recommended minimum of 5 years. Non-adherence to AET has been associated with higher mortality risks and healthcare costs. The few AET adherence-enhancing interventions evaluated were mainly limited to the provision of information and reminders, with inconclusive results. Our team has developed the "SOIE" (Soutien, Outils, Information, Entraide) program for women who have a first AET prescription. This program, developed in collaboration with clinicians and breast cancer survivors, includes group sessions (in person and online) and short individual interventions tailored to women's needs. We will pilot-test the SOIE program to evaluate: a) effect of the program on factors expected to influence AET adherence; b) program acceptability; c) feasibility of program delivery; d) feasibility of conducting a large-scale study to evaluate cost-effectiveness. We will conduct a pilot randomized controlled trial (RCT). Fifty (50) women will receive the program and 50 women will receive the usual care. Quantitative and qualitative data will be collected among participating women and health professionals delivering the program. Results from this study will provide crucial information for program optimization and for the design of the large-scale multicenter RCT. This pilot study represents the cornerstone for the implementation of a novel program that has the potential to contribute to the efforts to improve both breast cancer survival and the survivorship experience.
Competitiondate
201603
Approvedterm2
1 yr 10 mths
Pinamesdelim
Lauzier, Sophie
Approvedterm
1 an 10 mois
Cihrcontribution2
~ $133,787~ $0~